CAC
Cowen and Company’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,129,103
| Closed | -$210M | – | 602 |
|
|
2024
Q2 | $210M | Sell |
5,129,103
-500,000
| -9% | -$20.4M | 5.76% | 5 |
|
|
2024
Q1 | $144M | Hold |
5,629,103
| – | – | 5.56% | 3 |
|
|
2023
Q4 | $50.9M | Hold |
5,629,103
| – | – | 3.34% | 4 |
|
|
2023
Q3 | $35.9M | Hold |
5,629,103
| – | – | 2.51% | 6 |
|
|
2023
Q2 | $62.4M | Buy |
5,629,103
+1,036,137
| +23% | +$11.5M | 5.17% | 3 |
|
|
2023
Q1 | $70.5M | Buy |
4,592,966
+304,600
| +7% | +$4.68M | 8.28% | 2 |
|
|
2022
Q4 | $95.2M | Buy |
4,288,366
+500,000
| +13% | +$11.1M | 9.95% | 2 |
|
|
2022
Q3 | $61.9M | Buy |
3,788,366
+1,524,216
| +67% | +$24.9M | 5.92% | 3 |
|
|
2022
Q2 | $32.9M | Buy |
+2,264,150
| New | +$32.9M | 3.18% | 9 |
|